ArticleEClinicalMedicine2025

Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma (NICE): a multicentre, single-arm, exploratory phase 2 study.

Liying Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.